Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

F Komada

Showing results (21-30 of 52) with videos related to

Pageof 6
Sort By:
Biological & Pharmaceutical Bulletin|November 1, 1993
Cytoprotective effects of epidermal growth factor (EGF) ointment containing nafamostat, a protease inhibitor, on tissue damage at burn sites in ratsY Kiyohara, K Nishiguchi, F Komada, et al.
Clinical Pharmacology and Therapeutics|May 1, 1997
Genotyping of N-acetylation polymorphism and correlation with procainamide metabolismK Okumura, T Kita, S Chikazawa, et al.
Biological & Pharmaceutical Bulletin|January 9, 1999
Effects of Cu, Zn-superoxide dismutase delivered by genetically modified skin fibroblasts on cold-induced skin edema in ratsK Nishiguchi, F Komada, Y Tanigawara, et al.
Journal of Pharmacobio-Dynamics|January 1, 1991
Improvement in wound healing by epidermal growth factor (EGF) ointment. II. Effect of protease inhibitor, nafamostat, on stabilization and efficacy of EGF in burnY Kiyohara, F Komada, S Iwakawa, et al.
Therapeutic Drug Monitoring|July 31, 2001
Identification of N-acetyltransferase 2 and CYP2C19 genotypes for hair, buccal cell swabs, or fingernails compared with bloodY Tanigawara, T Kita, M Hirono, et al.
Biological & Pharmaceutical Bulletin|April 4, 2000
Cellular pharmacokinetic aspects of reversal effect of itraconazole on P-glycoprotein-mediated resistance of anticancer drugsK Takara, Y Tanigawara, F Komada, et al.
Japanese Journal of Clinical Oncology|December 1, 1988
Clinical response to busramustine (KM-2210) in chronic lymphocytic leukemia: a pilot evaluation of estrogen receptor in relation to its therapeutic effectM Nishikawa, Y Uemura, F Komada, et al.
Pharmaceutical Research|December 1, 1990
Improvement in wound healing by epidermal growth factor (EGF) ointment. I. Effect of nafamostat, gabexate, or gelatin on stabilization and efficacy of EGFK Okumura, Y Kiyohara, F Komada, et al.
Pharmaceutical Research|November 5, 1997
Enhanced anti-inflammatory effects of Cu, Zn-superoxide dismutase delivered by genetically modified skin fibroblasts in vitro and in vivoK Okumura, K Nishiguchi, Y Tanigawara, et al.
Cancer Research|August 15, 1991
Expression of three major protein kinase C isozymes in various types of human leukemic cellsF Komada, M Nishikawa, Y Uemura, et al.
Pageof 6

Showing results (21-30 of 52) with videos related to

Sort By:
Pageof 6
Biological & Pharmaceutical Bulletin|November 1, 1993
Cytoprotective effects of epidermal growth factor (EGF) ointment containing nafamostat, a protease inhibitor, on tissue damage at burn sites in ratsY Kiyohara, K Nishiguchi, F Komada, et al.
Clinical Pharmacology and Therapeutics|May 1, 1997
Genotyping of N-acetylation polymorphism and correlation with procainamide metabolismK Okumura, T Kita, S Chikazawa, et al.
Biological & Pharmaceutical Bulletin|January 9, 1999
Effects of Cu, Zn-superoxide dismutase delivered by genetically modified skin fibroblasts on cold-induced skin edema in ratsK Nishiguchi, F Komada, Y Tanigawara, et al.
Journal of Pharmacobio-Dynamics|January 1, 1991
Improvement in wound healing by epidermal growth factor (EGF) ointment. II. Effect of protease inhibitor, nafamostat, on stabilization and efficacy of EGF in burnY Kiyohara, F Komada, S Iwakawa, et al.
Therapeutic Drug Monitoring|July 31, 2001
Identification of N-acetyltransferase 2 and CYP2C19 genotypes for hair, buccal cell swabs, or fingernails compared with bloodY Tanigawara, T Kita, M Hirono, et al.
Biological & Pharmaceutical Bulletin|April 4, 2000
Cellular pharmacokinetic aspects of reversal effect of itraconazole on P-glycoprotein-mediated resistance of anticancer drugsK Takara, Y Tanigawara, F Komada, et al.
Japanese Journal of Clinical Oncology|December 1, 1988
Clinical response to busramustine (KM-2210) in chronic lymphocytic leukemia: a pilot evaluation of estrogen receptor in relation to its therapeutic effectM Nishikawa, Y Uemura, F Komada, et al.
Pharmaceutical Research|December 1, 1990
Improvement in wound healing by epidermal growth factor (EGF) ointment. I. Effect of nafamostat, gabexate, or gelatin on stabilization and efficacy of EGFK Okumura, Y Kiyohara, F Komada, et al.
Pharmaceutical Research|November 5, 1997
Enhanced anti-inflammatory effects of Cu, Zn-superoxide dismutase delivered by genetically modified skin fibroblasts in vitro and in vivoK Okumura, K Nishiguchi, Y Tanigawara, et al.
Cancer Research|August 15, 1991
Expression of three major protein kinase C isozymes in various types of human leukemic cellsF Komada, M Nishikawa, Y Uemura, et al.
Pageof 6